Lifecore Biomedical, Inc. \De\ (LFCR) Short-Term Debt issuances (2016 - 2025)
Historic Short-Term Debt issuances for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 12 years, with Q1 2025 value amounting to -$6.0 million.
- Lifecore Biomedical, Inc. \De\'s Short-Term Debt issuances fell 29769.36% to -$6.0 million in Q1 2025 from the same period last year, while for Feb 2025 it was $129.3 million, marking a year-over-year increase of 12080.64%. This contributed to the annual value of $149.6 million for FY2024, which is 37563.12% up from last year.
- According to the latest figures from Q1 2025, Lifecore Biomedical, Inc. \De\'s Short-Term Debt issuances is -$6.0 million, which was down 29769.36% from -$13.1 million recorded in Q4 2024.
- Over the past 5 years, Lifecore Biomedical, Inc. \De\'s Short-Term Debt issuances peaked at $146.5 million during Q2 2024, and registered a low of -$32.0 million during Q1 2023.
- For the 5-year period, Lifecore Biomedical, Inc. \De\'s Short-Term Debt issuances averaged around $17.4 million, with its median value being $4.0 million (2022).
- Per our database at Business Quant, Lifecore Biomedical, Inc. \De\'s Short-Term Debt issuances skyrocketed by 44900.99% in 2023 and then tumbled by 49245.03% in 2024.
- Lifecore Biomedical, Inc. \De\'s Short-Term Debt issuances (Quarter) stood at $18.0 million in 2021, then crashed by 77.78% to $4.0 million in 2022, then tumbled by 155.3% to -$2.2 million in 2023, then crashed by 492.45% to -$13.1 million in 2024, then surged by 54.22% to -$6.0 million in 2025.
- Its last three reported values are -$6.0 million in Q1 2025, -$13.1 million for Q4 2024, and $1.9 million during Q3 2024.